SCHEMBL5730696

SCHEMBL5730696

CC(C)(C)OC(=O)[C@]1(CC#N)CCCN1

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
ARG1 P05089 1/20 0.33
ARG2 P78540 1/20 0.33
JAK2 O60674 4/20 0.31
JAK1 P23458 4/20 0.31
CYP2D6 P10635 3/20 0.30
SLC6A2 P23975 3/20 0.30
SLC6A4 P31645 3/20 0.30
SLC6A3 Q01959 3/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170436 0.79 ARG1 (0.37) ARG1ARG2CYP2D6SLC6A2SLC6A4
SCHEMBL17395338 0.79 ARG1 (0.37) ARG1ARG2CYP2D6SLC6A2SLC6A4
SCHEMBL8116636 0.75 ARG1 (0.40) ARG1ARG2CYP2D6SLC6A2SLC6A4
SCHEMBL4711308 0.75 ARG1 (0.36) ARG1ARG2CYP2D6SLC6A2SLC6A4
SCHEMBL2334849 0.75 CYP2C19 (0.36) ALDH1A1ARG1ARG2
SCHEMBL17395342 0.73 CYP2C19 (0.39) ALDH1A1ARG1ARG2
SCHEMBL8123993 0.73 ARG1 (0.42) ARG1ARG2CYP2D6SLC6A2SLC6A4
SCHEMBL8106291 0.72 CYP2D6 (0.33) MEN1ALDH1A1KMT2AARG1ARG2
SCHEMBL7978321 0.70
SCHEMBL17395386 0.70 CYP2C19 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651623-A4 HEXAHYDRODIAZEPINONES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO INC (US) 2006-10-04 EP disclosed
EP-1651623-A2 HEXAHYDRODIAZEPINONES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES Merck & Co., Inc. (US) 2006-05-03 EP disclosed
WO-2005011581-A2 HEXAHYDRODIAZEPINONES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO., INC. (US) 2005-02-10 WO disclosed